MassRoots Inc. went through a massive transition this week. In a span of two days, the Denver-based marijuana tech and social media firm no longer had its founder at the helm and no longer had an acquisition valued at $12 million on the docket.
As CBD drug Epidiolex moves through FDA’s approval pipeline, the GW Pharmaceuticals product developed for treating certain types of epilepsy is watched cautiously by the hemp industry and optimistically by the medical community.
For a hybrid, Space Queen draws out the more playfully sativa headiness of the Romulan in the same way your old dog still surprises you with a spry day every now and then. With winter drawing to a close, I love strains like this to boost my mood.